Ma, Shaohua <br/><br/>
The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.  [electronic resource] 

 -  Cancer biomarkers : section A of Disease markers   
 - 155-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1875-8592 
<br/><br/><label>Standard No.: </label>10.3233/CBM-2012-0246  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Neoplasm--blood<br/>Biomarkers, Tumor--blood<br/>CA-125 Antigen--blood<br/>CA-19-9 Antigen--blood<br/>Carcinoembryonic Antigen--blood<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoassay--methods<br/>Kaplan-Meier Estimate<br/>Keratin-19--blood<br/>Lung Neoplasms--blood<br/>Male<br/>Membrane Proteins--blood<br/>Middle Aged<br/>Neoplasm Staging<br/>Outcome Assessment, Health Care--statistics & numerical data<br/>Phosphopyruvate Hydratase--blood<br/>Prognosis<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Serpins--blood